Stoke Therapeutics (STOK)10% owner sold ~$23M
Skorpios Trust, 10% owner at Stoke Therapeutics, sold ~$23M of Stoke Therapeutics shares.
- ~$23M
- Approx. value · 2M sh @ $11.50
- 6.91M
- Holds after · shares reported
- Traded
- Dec 23, 2024
- Filed
- Dec 27, 2024
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- Nov 1, 2024InsiderOfficer sold ~$127K of STOK shares in the open market
- Dec 2, 2024InsiderOfficer sold ~$121K of STOK shares in the open market
- Dec 6, 2024Insider · 3 peopleInsiders: 3 sales (~$381K)
- Dec 9, 2024Insider · 3 peopleInsiders: 4 sales (~$308K)
- Dec 23, 2024 · this disclosureInsider10% owner sold ~$23M of STOK shares in the open market
What came next
- Mar 18, 2025Insider · 3 peopleInsiders: 3 sales (~$143K)
- Mar 19, 2025Insider · 3 peopleInsiders: 3 sales (~$117K)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Stoke Therapeutics
For Stoke Therapeutics, OQRO holds 3 insider filings (SEC Form 4 or Form 144) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its STOK page.
Other recent filings by Skorpios Trust, 10% owner
The full history of Skorpios Trust, 10% owner is on the profile page.
How this filing works
Other disclosures at Stoke Therapeutics
- SEC Form 144Oct 2, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 4Oct 2, 2026
- SEC Form 13F-HRMay 15, 2026
- SEC Form 13F-HRMay 14, 2026
- SEC Form 13F-HRFeb 17, 2026
Everything OQRO holds on this company is on its STOK page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO Pro is a paid subscription. You see the price before you pay
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data